One Health Trust researchers estimate that the economic burden of Alzheimer’s disease will increase at least two-fold every decade.

One Health Trust researchers estimate that the economic burden of Alzheimer’s disease will increase at least two-fold every decade.

Out in eClinicalMedicine, One Health Trust researchers projected the global, regional, and national economic burden of Alzheimer’s disease and related dementias (ADRDs) from 2019 to 2050. In 2019, the global value of statistical life (VSL)-based economic burden of ADRDs was an estimated $2.8 trillion. Researchers projected that this economic burden would increase to $4.7 trillion in 2030 and up to $16.9 trillion in 2050. Low- and middle-income countries would account for 65% of the global VSL-based economic burden in 2050, as compared with only 18% in 2019.  

Find the article from eClinicalMedicine, here.